GENE ONLINE|News &
Opinion
Blog

ESMO 2024
ESMO 2024 Prostate CancerBayer
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
ESMO 2024 highlights
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
ESMO 2024 ESMO 2024Cancer Screening
ESMO Introduces New Framework for Evaluating Tumor-Agnostic Potential of Cancer Treatments
2024-09-03
LATEST
Malin and Goetz Updates SPF 30 Mineral Sunscreen Documentation on DailyMed
2026-10-09
Henry Schein Updates Vitamin A & D Ointment Product Documentation on DailyMed
2026-10-09
Mary Kay Updates Clear Proof Acne Treatment Gel Labeling in DailyMed Database
2026-10-09
Dechra Veterinary Products Updates Muricin Ointment Documentation on DailyMed
2026-10-09
Cardinal Health Updates LEADER Daily Moisturizer Product Documentation on DailyMed
2026-10-09
S.S.S. Company Updates Curasore Pramoxine Hydrochloride Product Information on DailyMed
2026-10-09
DeLaval Inc. Updates TITAN Topical Antiseptic Product Information on DailyMed
2026-10-09
READ MORE
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
2026-10-23
ESMO Congress 2026 (Oncology Breakthroughs)
Madrid, Spain
2026-10-27
ESGCT 2026 (Gene & Cell Therapy)
Hamburg, Germany
2026-11-09
BIO-Europe 2026 (Partnering & Dealmaking)
Cologne, Germany
2026-11-15
HLTH 2026 (Nov 15–18, Las Vegas) (Healthcare innovation)
Las Vegas, Nevada
2026-11-16
MEDICA 2026 (Global Medtech)
Düsseldorf, Germany
SEE MORE
Scroll to Top